Rx · PZN 19734087

RYBREVANT 1600 mg solution for injection vial

German trade nameRYBREVANT 1600 mg Injektionslösung Durchstechflasche

Active ingredientAmivantamabPharmaceutical formSolution for injection/infusion

Only sporadically available

2.4

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €4,381

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for RYBREVANT 1600 mg solution for injection vial.

Review purchasing terms

RYBREVANT 1600 mg solution for injection vial contains the active ingredient Amivantamab and comes as Solution for injection/infusion. One pack size is recorded (PZN 19734087). The pharma availability index for German wholesale stands at 2.4 out of 10 over the past 30 days – the pack was therefore only sporadically available.

RYBREVANT 1600 mg solution for injection vial was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.